C A van Els
Overview
Explore the profile of C A van Els including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
186
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stittelaar K, Hoogerhout P, Ovaa W, van Binnendijk R, Poelen M, Roholl P, et al.
Vaccine
. 2001 Sep;
20(1-2):249-61.
PMID: 11567771
Lipopeptidic formulations have been described as efficient activators of cytotoxic T lymphocytes (CTL). To better understand the pathway via which lipopeptides reach the MHC class I molecules we studied the...
2.
van Els C, Herberts C, van der Heeft E, Poelen M, Van der Kooi A, Hoogerhout P, et al.
Eur J Immunol
. 2000 Apr;
30(4):1172-81.
PMID: 10760807
We studied the natural MHC class I display of measles virus (MV) epitopes. Peptide ligands associated with HLA-A*0201 were purified from a B lymphoblastoid cell line prior to and after...
3.
Taams L, van Rensen A, Poelen M, van Els C, Besseling A, WAGENAAR J, et al.
Eur J Immunol
. 1998 Oct;
28(9):2902-12.
PMID: 9754577
We here show that anergic T cells are active mediators of T cell suppression. In co-culture experiments, we found that anergic T cells, derived from established rat T cell clones...
4.
van der Heeft E, ten Hove G, Herberts C, Meiring H, van Els C, de Jong A
Anal Chem
. 1998 Sep;
70(18):3742-51.
PMID: 9751018
A microcapillary column switching high-performance liquid chromatography (HPLC) system was developed for the separation of major histocompatibility complex (MHC) class I associated peptides. Combination of the column switching system with...
5.
Schipper R, van Els C, DAmaro J, Oudshoorn M
Hum Immunol
. 1996 Dec;
51(2):95-8.
PMID: 8960911
Vaccination with peptides that induce a specific immune response is a potential prophylactic or therapeutic strategy against viral infections and tumors. Because of the extensive polymorphism of the HLA loci,...
6.
van Baalen C, Klein M, Huisman R, Dings M, Kerkhof Garde S, Geretti A, et al.
J Gen Virol
. 1996 Aug;
77 ( Pt 8):1659-65.
PMID: 8760412
Human immunodeficiency virus type 1 (HIV-1) Gag-specific cytotoxic T lymphocyte (CTL) responses were studied in seven seropositive long-term asymptomatic individuals (CDC A1) with stable CD4 counts for more than 8...
7.
Geretti A, Dings M, van Els C, van Baalen C, Wijnholds F, Borleffs J, et al.
J Infect Dis
. 1996 Jul;
174(1):34-45.
PMID: 8656011
The frequencies of human immunodeficiency virus type 1 (HIV-1) Gag- and Epstein-Barr virus (EBV)-specific cytotoxic T lymphocyte precursors (CTLp) were studied longitudinally in peripheral blood mononuclear cells from 9 HIV-1-infected...
8.
Geretti A, van Baalen C, Borleffs J, van Els C, Osterhaus A
Scand J Immunol
. 1994 Apr;
39(4):355-62.
PMID: 7908456
Peripheral blood mononuclear cells from 36 asymptomatic HIV-1 seropositive individuals were tested longitudinally for in vitro T-cell proliferation and IL-2 production in response to synthetic peptides spanning the entire gp120...
9.
van Baalen C, Klein M, Geretti A, Keet R, Miedema F, van Els C, et al.
AIDS
. 1993 Jun;
7(6):781-6.
PMID: 7689847
Objective: To identify HIV-1 Gag cytotoxic T-lymphocyte (CTL) epitopes and HLA restriction of their recognition, and to define precursor frequencies of HIV-1 Gag-specific CTL in the blood of seropositive individuals....
10.
Geretti A, van Els C, van Baalen C, Poelen M, Osterhaus A
J Immunol Methods
. 1993 May;
161(1):129-33.
PMID: 8486924
No abstract available.